MedTrace Logo

Post-COVID-19 Monitoring in Routine Health Insurance Data

NCT05074953 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 157134

Last updated 2024-09-25

No results posted yet for this study

Summary

The SARS-CoV-2 infection was in 2020 responsible for new disease related chronic conditions which have been referred to as Post-COVID. To date it is still unknown how common this condition is and which symptoms are related to it. The aim of the study is to monitor the onset of these conditions in a large observational study consisting of German health insurance data.

Conditions

  • Virus Diseases
  • Epidemiology

Interventions

OTHER

Exposed to a SARS-CoV-2 infection

The study compared humans exposed to the SARS-CoV-2 infection with a matched group of those not exposed. No Intervention was applied.

Sponsors & Collaborators

  • InGef - Institut für angewandte Gesundheitsforschung Berlin GmbH

    collaborator UNKNOWN

  • BARMER Institut für Gesundheitssystemforschung (bifg)

    collaborator UNKNOWN

  • AOK Bayern

    collaborator INDUSTRY

  • AOK PLUS

    collaborator INDUSTRY

  • DAK Gesundheit

    collaborator OTHER

  • Techniker Krankenkasse

    collaborator OTHER

  • Technische Universität Dresden

    lead OTHER

Principal Investigators

  • Falko Tesch · Center for Evidence-Based Healthcare, Technische Universität Dresden

  • Jochen Schmitt, MD, MPH · Center for Evidence-Based Healthcare, Technische Universität Dresden

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-01
Primary Completion
2023-06-30
Completion
2023-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05074953 on ClinicalTrials.gov